Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | AMGN | GILD | CELG | ILMN |
| Company | Celldex Therapeutics | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 41.92 | 300.12 | 65.57 | 108.01 | 111.31 |
| High | 42.56 | 306.11 | 65.61 | 108.59 | 112.17 |
| Low | 40.72 | 298.89 | 64.87 | 107.27 | 108.54 |
| Last | 41.20 | 305.19 | 64.87 | 108.24 | 110.46 |
| Change | -1.01 | +4.89 | -0.59 | +0.11 | -2.36 |
| % Change | -2.39% | +1.63% | -0.90% | +0.10% | -2.09% |
| Volume | 179,149 | 1,449,806 | 2,466,010 | 191,230,496 | 1,726,438 |
| 20-Day Average Volume | 589,950 | 2,794,966 | 7,323,421 | 16,188,930 | 1,555,042 |
| Previous Close | 42.21 | 300.30 | 65.46 | 108.13 | 112.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 39.11 | 277.18 | 66.31 | 108.17 | 120.85 |
| 20-Day Raw Stochastic | 68.96% | 70.84% | 15.12% | 63.25% | 8.51% |
| 20-Day Relative Strength | 52.32% | 64.85% | 33.13% | 64.69% | 35.10% |
| Weighted Alpha | +6.30 | +30.67 | -20.84 | +46.30 | -45.44 |
| Today's Opinion | 56% Buy | 56% Buy | 100% Sell | 100% Buy | 88% Sell |
| Previous Opinion | 72% Buy | 40% Buy | 100% Sell | 100% Buy | 88% Sell |
| Last Month's Opinion | 56% Buy | 8% Sell | 100% Sell | 100% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.09% since 05/01/24 | +9.80% since 05/01/24 | -0.72% since 05/01/24 | -1.97% since 11/13/19 | -11.15% since 05/01/24 |
| Low | 38.75 on 05/02/24 | 274.90 on 05/02/24 | 64.33 on 05/03/24 | 107.27 on 11/20/19 | 108.54 on 05/08/24 |
| High | 43.35 on 05/07/24 | 322.60 on 05/03/24 | 66.14 on 05/07/24 | 110.53 on 11/14/19 | 127.89 on 05/03/24 |
| 1-Month | |||||
| %Chg | +3.07% since 04/08/24 | +13.13% since 04/08/24 | -6.31% since 04/08/24 | +5.14% since 10/18/19 | -14.86% since 04/08/24 |
| Low | 35.65 on 04/26/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 102.40 on 10/21/19 | 108.54 on 05/08/24 |
| High | 43.35 on 05/07/24 | 322.60 on 05/03/24 | 69.95 on 04/09/24 | 110.70 on 11/13/19 | 135.26 on 04/09/24 |
| 3-Month | |||||
| %Chg | +9.17% since 02/08/24 | +3.29% since 02/08/24 | -11.87% since 02/08/24 | +13.63% since 08/20/19 | -22.71% since 02/08/24 |
| Low | 35.03 on 02/13/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 93.41 on 08/23/19 | 108.54 on 05/08/24 |
| High | 53.18 on 03/04/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 110.70 on 11/13/19 | 147.70 on 02/09/24 |
| 6-Month | |||||
| %Chg | +54.57% since 11/08/23 | +11.45% since 11/08/23 | -16.51% since 11/08/23 | +14.14% since 05/20/19 | +0.07% since 11/08/23 |
| Low | 25.08 on 11/09/23 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 89.08 on 07/23/19 | 89.00 on 11/10/23 |
| High | 53.18 on 03/04/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 110.70 on 11/13/19 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,359,581 | 161,091,424 | 81,502,736 | 77,035,920 | 17,972,226 |
| Shares Outstanding, K | 55,901 | 536,435 | 1,245,077 | 711,714 | 159,300 |
| Annual Sales | 6,880,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | -141,430,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 4,130,000 | 7,447,000,000 | 6,686,000,000 | 4,520,000,000 | 1,076,000,000 |
| Last Quarter Net Income | -43,310,000 | -113,000,000 | -4,170,000,000 | 1,691,000,000 | -126,000,000 |
| 60-Month Beta | 1.60 | 0.60 | 0.22 | 1.41 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 2.99 on 10/31/19 | 0.09 on 05/02/24 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 10/31/19 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.08 | 16.26 | 10.99 | 135.20 |